A new minimally-invasive procedure is giving patients at Outer Banks Health the latest treatment option for benign prostatic ...

In early October 2026, PROCEPT BioRobotics added veteran cardiac surgeon Dr. Michael Mack to its board as an independent ...

Cameron C. Jones, MD, discusses patient selection for Aquablation, including prostate size, anatomy, and factors that may favor alternative BPH procedures. In this video, Cameron C. Jones, MD, of ...

Milestone highlights hospital’s experience with advanced, minimally invasive treatment for enlarged prostate DELRAY BEACH, Fla. – September 17, 2026 – Delray Medical Center is celebrating a ...

SAN FRANCISCO, Sept. 12, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after ...

A 5-year-old child has died after being struck by a vehicle on Foxon Road in East Haven, police said Thursday evening. The university system says that they are fixing the issues, as those who work at ...

South County Health has become the first health care organization in Rhode Island to join the Mayo Clinic Care Network, giving local doctors direct access to Mayo Clinic specialists, research and ...

Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.

The Youth Fishing Tournament at Day at the Docks is a wonder-filled event, from the smallest pinfish to the largest fish.

PROCEPT BioRobotics has an average rating of overweight and mean price target of $22.42, according to analysts polled by FactSet.

Insider buying activity at PROCEPT BioRobotics Corporation over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor ...